Evidence map›Paper›PMID 39201682›Full record

ArticleInternational journal of molecular sciences2024

In Vitro Investigation of the Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol, Identified from

Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Nopawit Khamto, Pornsuda Sutana, Pachuen Potup, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Catherine Léon and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Anti-Fibrotic Effect of Oleamide Identified from theInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Immunomodulatory and growth-promoting effects ofFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Watunyoo BuakaewDepartment of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.ORCID 0000-0002-0735-1941
Sucheewin KrobthongCenter of Excellence in Natural Products Chemistry (CENP), Department of Chemistry Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0003-4428-4140
Yodying YingchutrakulNational Center for Genetic Engineering and Biotechnology, NSTDA, Pathum Thani 12120, Thailand.ORCID 0000-0003-0701-4205
Nopawit KhamtoDepartment of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Pornsuda SutanaCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Pachuen PotupCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Yordhathai ThongsriCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0001-6771-4970
Krai DaowtakCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0002-2397-8381
Antonio FerranteDepartment of Immunopathology, South Australia (SA) Pathology, Women's and Children's Hospital, Adelaide, SA 5006, Australia.ORCID 0000-0002-2581-6407
Catherine LéonINSERM, UMR_S1255, Université de Strasbourg, Etablissement Français du Sang-GEST, 67000 Strasbourg, France.ORCID 0000-0002-8597-9929
Kanchana UsuwanthimCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0002-4039-5882

Funding

Reinventing University Program 2023, The Ministry of Higher Education, Science, Research and Innovation (MHESI), Thailand R2566A053Thailand Science Research and Innovation, and Naresuan University R2567B04
6 · The paper itself

Abstract

Liver fibrosis, characterized by excessive extracellular matrix deposition, is driven by activated hepatic stellate cells (HSCs). Due to the limited availability of anti-fibrotic drugs, the research on therapeutic agents continues. Here we have investigated

Indexed as

Hepatic Stellate CellsLiver CirrhosisMoringa oleiferaAntifibrotic AgentsCell LineHumansMolecular Docking SimulationPlant ExtractsProteomicsSignal TransductionTransforming Growth Factor beta1Antifibrotic AgentsPlant ExtractsTransforming Growth Factor beta11-phenyl-2-pentanolhepatic stellate cellliver fibrosismolecular docking analysisMoringa oleifera Lam.proteomics

Identifiers

PMID39201682
PMCPMC11354330

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.